| 0 (0%) | 03-03 01:54 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 38.21 | 1-year : | 40.87 |
| Resists | First : | 32.71 | Second : | 34.99 |
| Pivot price | 31.94  |
|||
| Supports | First : | 29.03 | Second : | 24.15 |
| MAs | MA(5) : | 31.8 |
MA(20) : | 32.57 |
| MA(100) : | 33.98 |
MA(250) : | 31.43 |
|
| MACD | MACD : | -0.5 |
Signal : | -0.5 |
| %K %D | K(14,3) : | 51.1 |
D(3) : | 47.5 |
| RSI | RSI(14): 45.3 |
|||
| 52-week | High : | 38.49 | Low : | 21.98 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ CEPI ] has closed above bottom band by 49.3%. Bollinger Bands are 5.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 32.32 - 32.45 | 32.45 - 32.57 |
| Low: | 31.27 - 31.42 | 31.42 - 31.57 |
| Close: | 31.68 - 31.91 | 31.91 - 32.14 |
Tue, 24 Feb 2026
Background Rates of Adverse events for Vaccine Evaluation in Africa (BRAVE) - Global Vaccine Data Network
Thu, 19 Feb 2026
Dr Umar Ahmad: My Fellowship at CEPI - CEPI
Thu, 12 Feb 2026
CEPI launches global plan to secure the future against epidemic and pandemic threats - CEPI
Mon, 02 Feb 2026
CEPI and Samsung Biologics collaborate to strengthen outbreak-ready vaccine production and global access - CEPI
Mon, 05 Jan 2026
CEPI calls for experts to join its Scientific Advisory Committee - CEPI
Wed, 17 Dec 2025
CEPI to Fund Pivotal Phase 3 Trial for Moderna’s mRNA Pandemic Influenza Candidate - CEPI
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|